Healthcare & Pharmaceutical

Autotransfusion Devices Market Analysis by Application (Orthopedic, Cardiovascular, Neurological, Gynecological, Obstetrics, and Other Surgeries); by Product Type (Autotransfusion Systems, and Accessories); and by End User (Hospitals, Specialty Clinics, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

Buy Now
Report ID: 4459 | Published On: Jan 30, 2023

Preview Analysis

Request Insights
Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022. Purchasing power in the country is expected to fell nearly by 2.5%.
On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.

In The News

  • ProCell Surgical Inc. announces its first patient blood management device, ProCell. Procell’s Sponge Blood Recovery is the extraction of blood during the surgical process in intraoperative transfusion.

  • Haemnotics Corporation join hands with Epic, a leading company for delivering electronic health record systems, to provide innovative medical solutions and better results for patients.

Global Autotransfusion Devices Market Definition

Autotransfusion devices are frequently employed to obtain and reinfuse blood from patients. Moreover, this equipment is used in cardiovascular, orthopedic, physiological, obstetrics and gynecology, and certain other intrusive treatments. In a cardiac patient, autotransfusion devices are utilized in the autotransfusion procedure, which contains centrifugation, aspiration, anticoagulation, reinfusion, and rinsing. Furthermore, it is used to concentrate the pump perfusate at the end of cardiopulmonary bypass (CPB).

With the progression of medical technology and an increasing disparity between blood supply and demand, autologous blood transfusion (ABT) has gained prominence in recent years; its efficiency and safety have steadily gained attention. ABT can prevent the severe damage induced by allogeneic blood transfusion, alleviate blood shortages, and save blood resources, while also reducing patient hardship. As a result, ABT has received increased attention, has become a popular approach in clinical practice, and is being more extensively utilized medically.

Autotransfusion systems are classified into three types: in-line, self-filling, and continuous. In-line means using a blood bag to gather fluid for future usage. A vacuum is used in the self-filling bag to help enhance the flow of fluid into the bag. Eventually, continuous autotransfusion employs an infusion pump and filter to deliver blood straight into the person's vascular access.

Global Autotransfusion Devices Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~USD 250 Million

Forecast Year Market Size (2033)

~USD 400 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Global Autotransfusion Devices Market Highlights Over 2023 - 2033

The global autotransfusion devices market is estimated to garner a revenue of nearly ~USD 400 million by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of around ~USD 250 million in the year 2022. The growth of the market can primarily be ascribed to the number of patients in need of surgical care. As per the WHO, over 2 million surgical procedures were performed in 2018 across the globe. Moreover, instances of surgical burden are to expected rise by approximately 30% in the next few years. 

The rising need for blood donation and increased volumes of donated blood, combined with the rising need for blood transfusion, is expected to boost the growth of the global autotransfusion devices market. As per the reported data, globally, every year about 118.5 million units of donated blood are collected. Additionally, in India, nearly 25-30 thousand people require liver transplants and about 50,000 person gets a heart attack. Furthermore, around 6,721 people are waiting for organ transplantation in the United Kingdom.

autotransfusion-devices-market-overviewGet more information on this report:Download Sample PDF

Autotransfusion is the procedure of transferring a patient's own blood into their body during cardiac or orthopedic surgery after component separation, and filtration. On the other hand, allogeneic blood transfusions can result in tumor progression, post-operative infections, severe lung injury, post-operative cardiovascular failures, and early death. For instance, multiple patient-based analysts predict that the pervasiveness of transfusion-associated circulatory overload (TACO) and transfusion-related acute lung injury (TRALI) in the United States is about 1.0% and 0.1%, respectively. As a result, shifting the priority forward into cell salvage can greatly decrease the need for allogeneic blood transfusion, decreasing the likelihood of detrimental ailments. As a result, the switch toward autologous blood transfusion is an eminent trend that is predicted to drive the market’s growth.

Get more information on this report: Request Sample PDF

Global Autotransfusion Devices Market: Growth Drivers and Challenges

Growth Drivers

  • Growing Burden of Chronic Disease on the World

Deaths and impairments from chronic obstructive pulmonary illness are rising across most regions. Moreover, chronic disease potential consequences are also expanding. As a result, the treatment and surgery for a wide range of chronic diseases is anticipated to increase the demand for autotransfusion devices. According to the records of the National Library of Medicine, worldwide, every 3 in 5 deaths is caused by cardiovascular disease, cancer, chronic lung problems, and diabetes.

  •  The Rising Number of Surgical Procedures Operated Across the World

Cell salvage and blood transfusions are critical components of blood conservation during every surgical operation. Furthermore, the greater focus on ignoring the hazards connected with allogeneic transfusions, along with an expanding number of bleeding-intensive surgeries, is expected to propel overall market expansion over the coming years. Globally nearly 11% of worldwide disease requires surgical treatment. Furthermore, there are nearly 310 million surgical procedures are carried out every year.

  • Increase in the Number of People with Kidney Problems

Chronic kidney disease is a progressive illness that impacts more than 10% of the global population. Chronic kidney disease is more common in older adults, women, racial minorities, and individuals with diabetes and high blood pressure. Nearly 850 million people all over the world have developed some sort of kidney disease.

  •  Surge in Population Percentage of Old-Adult

According to the WHO, by 2030, every 1 in 6 people is likely to be aged 60 years or above. Moreover, between 2015-2050, the worldwide older population is to get double, from nearly 12% to 22%.

  •  Rising Need for Blood Transfusion

According to the World Health Organization, the global share of blood transfusion in children is 54%, and nearly 76% of adults above 60 years of age.


  • Higher Prevalence of Minimally Invasive Surgery - Minimal invasion is highly adopted, and factors such as less pain, fast recovery, minimal blood loss, and higher comfort of patients are resulting higher number of people choosing it over traditional surgery. Therefore, it is likely to hamper the market’s growth.
  • Increased Use of Hemostatic Devices for Transfusions
  • Difficulty in Separating Contaminants from Blood

Market Segmentation

The autotransfusion devices market is segmented and analyzed for demand and supply by application into orthopedic, cardiovascular, neurological, gynecological, obstetrics, and other surgeries. Out of all, the cardiovascular surgery segment is anticipated to hold the largest market size by the end of 2033. Increased instances of cardiovascular issues are creating higher demands for transplantation, surgery, and autotransfusion, which is likely to drive the growth of the segment. According to the World Health Organization, nearly 17.9 million people are dying of cardiovascular disease every year, and cardiovascular is the primary reason for most of the deaths in the world.

The autotransfusion devices market is segmented and analyzed for demand and supply by product type into autotransfusion systems, and accessories. Out of all, autotransfusion systems are expected to hold the highest market size by the end of 2033. Owing to their reliability in blood transfusion, autotransfusion systems are becoming more popular in both developed and emerging nations, which is predicted to propel expansion in this segment over the coming years. Furthermore, adaptability, transfusion reporting mechanisms, technological developments for enhanced clinical outcomes, and communication are predicted to propel the expansion of the dual-mode autotransfusion systems segment in the market by 2033. In November 2022, LivaNova US introduced the XtraTM autotransfusion system, which serves as a full blood management system. It combines three decades of expertise and advancements in cell salvage methods.

Our in-depth analysis of the global autotransfusion devices market includes the following segments:

              By Application

  • Orthopedic Surgery
  • Cardiovascular Surgery
  • Neurological Surgery
  • Gynecological Surgery
  • Obstetrics
  • Other Surgeries

             By Product Type

  • Autotransfusion Systems
  • Accessories

             By End User

  • Hospitals
  •  Specialty Clinics
  • Others

Global Autotransfusion Devices Market Regional Synopsis

The North America autotransfusion devices market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be ascribed to the account of higher cases of chronic disease among the population propelling the market growth in the United States. According to the Centers for Disease Control and Prevention, every 6 in 10 adults are living with a chronic disease, and every 4 in 10 have more than 1 chronic problem. Furthermore, there has been a rise in organ transplantation and other surgeries in the region, that is further predicted to surge the market’s growth in the region. In the United States, at the current time, nearly 121,000 people are waiting for kidney transplantation. Also, the region's sales growth is expected to be driven by the rising usage of autologous blood transfusion in significant cardiovascular and orthopedic surgeries, in addition to the existence of established healthcare facilities. For instance, as per the American Association of Blood Banks guidelines, postoperative and intraoperative autotransfusion are conducted in surgeries in which 20% of overall surgical bleeding is anticipated.

On the other hand, the Asia Pacific market is projected to expand at the fastest CAGR owing to the entry of new industry players, and the increasing acceptance of cell salvage technologies. Furthermore, the steadily expanding number of surgeries performed in China and India, along with the emerging health services, are expected to create significant growth possibilities for the region. According to the most recent statistical report, Chinese hospitals operated more than 81 million inpatient surgeries in 2021.


Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Global Autotransfusion Devices Market

    • ProCell Surgical Inc.

      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • BD (Becton, Dickinson and Company)
    • Fresenius SE & Co. KGaA
    • Medtronic
    • Beijing Jingjing Medical Equipment Co., Ltd.
    • Haematonics Corporation
    • LivaNova PLC
    • Zimmer Biomet
    • SARSTEDT AG & Co. KG
    • Gen World Medical Devices


Key Questions Answered in the Report

1) What are the major factors driving the growth of the autotransfusion devices market?

Ans: Rise in geriatric population, growing cases of chronic disease, higher blood donation & blood transfusion and rise in surgery are few factors likely to propel the market growth.

2) What would be the CAGR of autotransfusion devices market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 – 2033.

3) What are the challenges affecting the autotransfusion devices market growth?

Ans: Rising adoption of minimally invasive surgery, increased usage of hemostatic devices for the transfusions and inefficient separating technique of contaminant from the blood are the few factors likely to hamper the market growth.

4) Which region will provide more business opportunities for growth of autotransfusion devices market in future?

Ans: The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

5) Who are the major players dominating the autotransfusion devices market?

Ans: The major players in the market are ProCell Surgical Inc., BD (Becton, Dickinson and Company), Fresenius SE & Co. KGaA, Medtronic, Beijing Jingjing Medical Equipment Co., Ltd., Haematonics Corporation, LivaNova PLC, Zimmer Biomet, SARSTEDT AG & Co. KG, Gen World Medical Devices, and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the autotransfusion devices market?

Ans: The market is segmented by application, product type, end user, and by region.

8) Which segment captures the largest market size in application in the autotransfusion devices market?

Ans: The cardiovascular surgery is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Submit RFP    Buy Now Download Research Report Sample